| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of safety data in children after receiving two doses of ProQuad® (MMRV)
|
Klopfer, Stephanie O.
|
|
2014
|
32 |
52 |
p. 7154-7160
7 p.
|
artikel
|
| 2 |
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
|
van Dissel, Jaap T.
|
|
2014
|
32 |
52 |
p. 7098-7107
10 p.
|
artikel
|
| 3 |
Considerations around the introduction of a cholera vaccine in Bangladesh
|
Nelson, Christopher B.
|
|
2014
|
32 |
52 |
p. 7033-7036
4 p.
|
artikel
|
| 4 |
Determinants of influenza vaccination coverage rates among primary care patients in Krakow, Poland and the surrounding region
|
Nessler, Katarzyna
|
|
2014
|
32 |
52 |
p. 7122-7127
6 p.
|
artikel
|
| 5 |
Editorial Board/Aims and Scope
|
|
|
2014
|
32 |
52 |
p. IFC-
1 p.
|
artikel
|
| 6 |
Ethical considerations in post-market-approval monitoring and regulation of vaccines
|
Thompson, Alison
|
|
2014
|
32 |
52 |
p. 7171-7174
4 p.
|
artikel
|
| 7 |
Evaluation of cells and biological reagents for adventitious agents using degenerate primer PCR and massively parallel sequencing
|
McClenahan, Shasta D.
|
|
2014
|
32 |
52 |
p. 7115-7121
7 p.
|
artikel
|
| 8 |
Factors associated with seasonal influenza immunization among church-going older African Americans
|
Boggavarapu, Sahithi
|
|
2014
|
32 |
52 |
p. 7085-7090
6 p.
|
artikel
|
| 9 |
How high is a high risk? Prioritising high-risk individuals in an influenza pandemic
|
Littmann, Jasper
|
|
2014
|
32 |
52 |
p. 7167-7170
4 p.
|
artikel
|
| 10 |
Increasing engagement of clinicians in adult immunizations: Reflections on a decade and a half of research
|
Zimmerman, Richard K.
|
|
2014
|
32 |
52 |
p. 7040-7042
3 p.
|
artikel
|
| 11 |
Monitoring coverage of fully immunized children
|
Tsega, Asnakew
|
|
2014
|
32 |
52 |
p. 7047-7049
3 p.
|
artikel
|
| 12 |
Number needed to vaccinate to prevent hospitalizations of pregnant women due to inter-pandemic influenza in Sweden, 2003–2009
|
Merk, Hanna
|
|
2014
|
32 |
52 |
p. 7135-7140
6 p.
|
artikel
|
| 13 |
Qualitative motivators and barriers to pandemic vs. seasonal influenza vaccination among healthcare workers: A content analysis
|
Prematunge, Chatura
|
|
2014
|
32 |
52 |
p. 7128-7134
7 p.
|
artikel
|
| 14 |
Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children
|
Brady, Rebecca C.
|
|
2014
|
32 |
52 |
p. 7141-7147
7 p.
|
artikel
|
| 15 |
Rational design of medium supplementation strategy for improved influenza viruses production based on analyzing nutritional requirements of MDCK Cells
|
Huang, Ding
|
|
2014
|
32 |
52 |
p. 7091-7097
7 p.
|
artikel
|
| 16 |
Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study
|
Lundgren, Anna
|
|
2014
|
32 |
52 |
p. 7077-7084
8 p.
|
artikel
|
| 17 |
Safety of immunization during pregnancy: A review of the evidence of selected inactivated and live attenuated vaccines
|
Keller-Stanislawski, Brigitte
|
|
2014
|
32 |
52 |
p. 7057-7064
8 p.
|
artikel
|
| 18 |
Seasonal and pandemic influenza vaccine: Demand, supply and vaccine availability
|
Gellin, Bruce G.
|
|
2014
|
32 |
52 |
p. 7037-7039
3 p.
|
artikel
|
| 19 |
Seasonal variation in rates of emergency room visits and acute admissions following recommended infant vaccinations in Ontario, Canada: A self-controlled case series analysis
|
Hawken, Steven
|
|
2014
|
32 |
52 |
p. 7148-7153
6 p.
|
artikel
|
| 20 |
Surveillance of congenital rubella syndrome (CRS) in tertiary care hospitals in Hanoi, Vietnam during a rubella epidemic
|
Van Bang, Nguyen
|
|
2014
|
32 |
52 |
p. 7065-7069
5 p.
|
artikel
|
| 21 |
The ethics of disease eradication
|
Wilson, James
|
|
2014
|
32 |
52 |
p. 7179-7183
5 p.
|
artikel
|
| 22 |
The use of serosurveys following emergency vaccination, to recover the status of “foot-and-mouth disease free where vaccination is not practised”
|
Paton, D.J.
|
|
2014
|
32 |
52 |
p. 7050-7056
7 p.
|
artikel
|
| 23 |
Vaccination ethics
|
Viens, A.M.
|
|
2014
|
32 |
52 |
p. 7161-7162
2 p.
|
artikel
|
| 24 |
Variation in exemptions to school immunization requirements among New York State private and public schools
|
Lai, Yun-Kuang
|
|
2014
|
32 |
52 |
p. 7070-7076
7 p.
|
artikel
|
| 25 |
Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain
|
Gil-Prieto, Ruth
|
|
2014
|
32 |
52 |
p. 7043-7046
4 p.
|
artikel
|
| 26 |
Varicella-zoster virus vaccination under the exogenous boosting hypothesis: Two ethical perspectives
|
Luyten, Jeroen
|
|
2014
|
32 |
52 |
p. 7175-7178
4 p.
|
artikel
|
| 27 |
VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA
|
Feenstra, Femke
|
|
2014
|
32 |
52 |
p. 7108-7114
7 p.
|
artikel
|
| 28 |
What is the responsibility of national government with respect to vaccination?
|
Verweij, Marcel F.
|
|
2014
|
32 |
52 |
p. 7163-7166
4 p.
|
artikel
|
Tijdschrift beschrijving